Differentiation of primary central nervous system lymphomas and glioblastomas: Comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion mr imaging without and with contrast-leakage correction

American Journal of Neuroradiology

Volumn 34, Issue 6, 2013, Pages 1145-1149

  Toh, C H ^a   Wei, K C ^a   Chang, C N ^a   Ng, S H ^a   Wong, H F ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTRAST LEAKAGE CORRECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DYNAMIC SUSCEPTIBILITY CONTRAST ENHANCED PERFUSION NUCLEAR MAGNETIC RESONANCE IMAGING; FEMALE; GLIOBLASTOMA; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; RECEIVER OPERATING CHARACTERISTIC; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; GLIOBLASTOMA; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84880790640     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3383     Document Type: Article

References (24)

1. Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011;32:984-92.
2. Toh CH, Castillo M, Wong AM, et al. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008;29:471-75.
3. Zaharchuk G. Theoretical basis of hemodynamicMRimaging techniques to measure cerebral blood volume, cerebral blood flow, and permeability. AJNR Am J Neuroradiol 2007;28:1850-58.
4. Cha S. Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 2006;27:475-87.
5. Provenzale JM, Mukundan S, Barboriak DP. Diffusion-weighted and perfusion MR imaging for brain tumor characterization and assessment of treatment response. Radiology 2006;239:632-49.
6. Sugahara T, Korogi Y, Shigematsu Y, et al. Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 1999;23:232-37.
7. Cho SK, Na DG, Ryoo JW, et al. Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 2002;3:171-79.
8. Hartmann M, Heiland S, Harting I, et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003;338:119-22.
9. Calli C, Kitis O, Yunten N, et al. Perfusion and diffusionMRimaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58: 394-403.
10. Liao W, Liu Y, Wang X, et al. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009;50:217-25.
11. Lee IH, Kim ST, Kim HJ, et al. Analysis of perfusion weighted image of CNS lymphoma. Eur J Radiol 2010;76:48-51.
12. Mangla R, Kolar B, Zhu T, et al. Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiatecommonenhancing malignant lesions of the brain. AJNR Am J Neuroradiol 2011;32:1004-10.
13. Wang S, Kim S, Chawla S, et al. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011;32:507-14.
14. Ma JH, Kim HS, Rim NJ, et al. Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions. AJNR Am J Neuroradiol 2010;31:1699-706.
15. Boxerman JL, Schmainda KM, Weisskoff RM. Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859-67.
16. Server A, Graff BA, Orheim TE, et al. Measurements of diagnostic examination performance and correlation analysis using microvascular leakage, cerebral blood volume, and blood flow derived from 3T dynamic susceptibility-weighted contrast-enhanced perfusion MRimaging in glial tumor grading. Neuroradiology 2011;53:435-47.
17. Molnár PP, O'Neill BP, Scheithauer BW, et al. The blood-brain barrier in primary CNS lymphomas: ultrastructural evidence of endothelial cell death. Neuro Oncol 1999;1:89-100.
18. Warnke PC, Timmer J, Ostertag CB, et al. Capillary physiology and drug delivery in central nervous system lymphomas. Ann Neurol 2005;57:136-39.
19. Takeuchi H, Matsuda K, Kitai R, et al. Angiogenesis in primary central nervous system lymphoma (PCNSL). J Neurooncol 2007;84: 141-45.
20. Schramm P, Xyda A, Klotz E, et al. DynamicCTperfusion imaging of intra-axial brain tumours: differentiation of high-grade gliomas from primary CNS lymphomas. Eur Radiol 2010;20:2482-90.
21. Emblem KE, Mouridsen K, Borra RJ, et al. Does DSC-derived CA extravasation correlate with DCE Ktrans? In: Procedures of the International Society of Magnetic Resonance in Medicine, Montreal, Quebec, Canada. May 6-13, 2011;1:791.
22. Sadeghi N, D'Haene N, Decaestecker C, et al. Apparent diffusion coefficient and cerebral blood volume in brain gliomas: relation to tumor cell density and tumor microvessel density based on stereotactic biopsies. AJNR Am J Neuroradiol 2008;29:476-82.
23. Cha S, Lupo JM, Chen MH, et al. Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility- weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007;28:1078-84.
24. Boxerman JL, Prah DE, Paulson ES, et al. The role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison withMIONas a criterion standard. AJNR Am J Neuroradiol 2012;33:1081-87.